Product Program year 2023 Source: CMS Open Payments

Slynd

Drug Oral contraceptive

NDC 0642-7470-01

Open in the dashboard

General payments

$595,464

17,067 payments

Research payments

$3,760,893

497 payments

Through program year 2023, $595,464 in general payments and $3,760,893 in research payments were reported against Slynd (Oral contraceptive).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 General $595,464 17,067
2023 Research $2,366,227 352
2022 Research $1,394,667 145

Breakdown

Who paid General payments · program year 2023
  1. Exeltis, USA Inc. $595,464 17,067 payments
Top recipients General payments · program year 2023
  1. Michael Krychman Obstetrics & Gynecology · Costa Mesa, CA $53,052 9% · 8 payments
  2. Youssef Mouhayar Obstetrics & Gynecology · Miami, FL $48,967 8% · 6 payments
  3. Ingrid Paredes Obstetrics & Gynecology · Miami, FL $16,848 3% · 3 payments
  4. John Thoppil Obstetrics & Gynecology · Austin, TX $14,105 2% · 11 payments
  5. Ana Eduardo Obstetrics & Gynecology · Austin, TX $12,045 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Obstetrics & Gynecology $372,570 64% · 4,757 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $44,236 8% · 917 practitioners
  3. Nurse Practitioner, Women's Health Nurse Practitioner $33,192 6% · 699 practitioners
  4. Advanced Practice Midwife $26,620 5% · 602 practitioners
  5. Physician Assistant $15,740 3% · 355 practitioners

The top 5 of 77 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Florida $135,395 23% · 787 recipients
  2. Texas $93,955 16% · 1,033 recipients
  3. California $80,555 14% · 430 recipients
  4. New York $26,351 4% · 514 recipients
  5. Maryland $18,229 3% · 195 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

1,388

Prescriptions dispensed, refills included

Drug cost

$298,889

Paid at the pharmacy, in all

Prescribers

106

With 11 or more claims of it

Medicare Part D drugs matched to SLYND, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Slynd Drospirenone Same name 106 1,388 $298,889

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Angela Fitch Nurse Practitioner KY 30 $7,584 $35
Peter Wong Obstetrics & Gynecology DE 26 $4,749 $30
Abbie Mincks Obstetrics & Gynecology IN 21 $5,251 $42
Beth Killam Certified Nurse Midwife IL 18 $5,568 None on record
Joanna Santiesteban Obstetrics & Gynecology KY 18 $3,366 $28

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron
17,067 general · 497 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record